ANIP ANI Pharmaceuticals Inc

NASDAQ
$70.19

ANI Pharmaceuticals Inc (ANIP) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with ANIP's own trailing one-year pace, with 34% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
11
45 transactions
Purchases
$0
0 shares
Sales
$14.5M
183,129 shares
Net activity
-$14.5M
purchases less sales

How much of that selling was preplanned? 34% planned / 66% discretionary

10b5-1 plan sales $4.9M 30 transactions · 62,440 shares
Discretionary sales $9.6M 15 transactions · 120,689 shares

Largest single sale: $4.3M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $72.80 $207.5K 171,843 −1.6% of holding
Lalwani Nikhil PRESIDENT & CEO Sell 10b5-1 5,400 $74.30 $401.2K 344,489 −1.5% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $75.48 $37.7K 74,424 −0.7% of holding
Gutwerg Ori SVP, GENERICS Sell 3,162 $77.00 $243.5K 75,534 −4% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $81.36 $231.9K 174,693 −1.6% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $81.84 $40.9K 77,390 −0.6% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 3,313 $86.00 $284.9K 177,543 −1.8% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 2,850 $84.12 $239.7K 177,543 −1.6% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $82.03 $41.0K 77,890 −0.6% of holding
HAUGHEY THOMAS Director Sell 10b5-1 2,000 $80.88 $161.8K 38,878 −4.9% of holding
CAREY STEPHEN P. SVP & CFO Sell 10b5-1 3,312 $80.00 $265.0K 180,393 −1.8% of holding
Walsh Patrick D Director Sell 10,000 $80.63 $806.3K 38,432 −20.6% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $78.16 $39.1K 78,390 −0.6% of holding
Gutwerg Ori SVP, GENERICS Sell 2,772 $79.50 $220.4K 78,696 −3.4% of holding
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 459 $79.21 $36.4K 38,271 −1.2% of holding
Lalwani Nikhil PRESIDENT & CEO Sell 55,000 $77.57 $4.3M 349,889 −13.6% of holding
Walsh Patrick D Director Sell 3,973 $80.75 $320.8K 48,432 −7.6% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $77.95 $39.0K 78,890 −0.6% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 3,162 $71.64 $226.5K 91,309 −3.3% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $72.62 $36.3K 79,390 −0.6% of holding
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 4,772 $74.91 $357.5K 38,730 −11% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 5,087 $74.13 $377.1K 51,946 −8.9% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 3,602 $74.18 $267.2K 94,471 −3.7% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 2,121 $74.22 $157.4K 101,387 −2% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 1,485 $75.00 $111.4K 57,033 −2.5% of holding
CAREY STEPHEN P. 2 fills SVP & CFO Sell 7,312 $75.50 $552.0K 189,543 −3.7% of holding
Walsh Patrick D Director Sell 6,000 $74.23 $445.4K 52,405 −10.3% of holding
Gutwerg Ori SVP, GENERICS Sell 2,060 $76.50 $157.6K 84,782 −2.4% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 417 $74.00 $30.9K 103,508 −0.4% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 5,323 $78.02 $415.3K 84,840 −5.9% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 1,730 $77.99 $134.9K 49,263 −3.4% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 2,084 $77.53 $161.6K 50,993 −3.9% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $76.80 $38.4K 69,329 −0.7% of holding
Mutz Christopher HEAD OF RARE DISEASE Sell 10b5-1 7,032 $76.55 $538.3K 92,566 −7.1% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 500 $84.33 $42.2K 74,374 −0.7% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 1,622 $82.40 $133.7K 58,564 −2.7% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 400 $82.32 $32.9K 74,874 −0.5% of holding
TANNENBAUM RENEE P Director Sell 1,800 $81.15 $146.1K 25,157 −6.7% of holding
Walsh Patrick D Director Sell 8,643 $86.88 $750.9K 61,405 −12.3% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 400 $87.27 $34.9K 75,274 −0.5% of holding
Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 94 $88.00 $8.3K 158,490 −0.1% of holding
Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 14,642 $89.07 $1.3M 158,584 −8.5% of holding
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 10b5-1 400 $90.09 $36.0K 75,674 −0.5% of holding
Davis Krista SVP, CHIEF HR OFFICER Sell 10b5-1 1,000 $98.04 $98.0K 60,186 −1.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.